CDC Home
CDC 24/7: Saving Lives. Protecting People.™

Centers for Disease Control and Prevention

CDC 24/7: Saving Lives. Protecting People.™

Centers for Disease Control and Prevention CDC 24/7: Saving Lives. Protecting People.™
ARBOVIRUS A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

Arbovirus Catalog

Browse the Catalog

ArboCat Home


Virus Sections

Virus Name/Prototype
Original Source
Method of Isolation
Virus Properties
Antigenic Relationship
Biologic Characteristics
Natural Host Range
Susceptibility to...
Experimental Infection...
Histopathology
Human Disease
Geographic Distribution
References
Remarks

References

History
Abbreviations
Information Exchange

User Functions

Login to Contribute
Create an Account
Retrieve Password
 

  Negishi   NEGV

Possible Arbovirus

No

3

Results of SALS surveys and information from the Catalogue.
Other Information
 

B
Section V - Antigenic Relationship and Lack of Relationship to Other Viruses
 
 
Negishi antigen or virus
Immune Serum HI(4) 8 units CF(4) NT(1)


RSSE(2i) 40/80 1/2
RSSE(4i) 160/640 1/4 64/256 1/4 1.5/2.7
Powassan(1i) 20/160 1/8
Powassan(4i) 20/640 1/32 32/256 1/8
JE Nak.-NIH(1i) <20/40
JE Nak.-NIH(4i) <20/1280 <4/64 0/2.3
MVE(1i) <20/160
MVE(4i) <4/128
WN(1i) <20/640
WN(5i) <4/128
SLE(1i) <20/160
SLE(4i) <4/64 0/2.7
Modoc(1i) <20/320
Modoc(4i) 40/1280 1/32 <4/128
YF17D(2i) <20/320
YF17D(5i) <20/1280 <4/32
 


NT: LNI given in dex.
Negishi Primary serum
Antigen or Virus HI(4) CF(4) NT(1)
RSSE 20/80 1/4
Powassan <20/80
JE Nak.-NIH <20/80
MVE 20/80 1/4
WN 20/80 1/4
SLE <20/80
Modoc <20/80
YF 17D <20/80
Negishi Hyperimmune serum
RSSE 640/1280 1/2 64/128 1/2 2.0/3.0
Powassan 320/1280 1/4 32/128 1/4
JE Nak.-NIH 160/1280 1/8 <4/128 0/3.0
MVE 2560/1280 2/1 4/128 1/32
WN 2560/1280 2/1 16/128 1/8
SLE 640/1280 1/2 16/128 1/8 2.0/3.0
Modoc 80/1280 1/16 <4/128
YF17D 320/1280 1/4 <4/128
The preliminary HI study revealed that the Negishi virus did not relate either to Group A, Group Bunyamwera or Akabane viruses. Above table indicates that the virus is most closely related to the tick-borne complex of B group. Antibody absorption tests carried out in 1961 at RFVL indicated that Negishi virus was a new member of the tick-borne complex since it diverged significantly from both Central European tick-borne encephalitis and louping ill viruses. [9]
In addition, see Reference [11] .
 
Download as PDF
<<<Click on the PDF icon to the left to view a copy of this virus entry in PDF format.
You can get a copy of the PDF viewer by clicking here.
 

Policies

Privacy

Contact Information

Centers for Disease Control and Prevention
1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636)
Contact CDC-INFO